Af­ter stop­ping Farx­i­ga tri­al ear­ly, As­traZeneca de­clares suc­cess in CKD treat­ment

Back in March, As­traZeneca an­nounced plans to halt a Phase III tri­al for its Farx­i­ga drug ahead of sched­ule af­ter see­ing “over­whelm­ing ef­fi­ca­cy” in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.